Allegis Group and SiriusPoint helped the online business insurance provider reach $160m of overall funding, reportedly boosting its valuation to $550m.

Bristol Myers Squibb helped the cell encapsulation technology developer raise cash that will help fund its international growth.

The micro-investment platform developer closed its latest round with backing from Susquehanna International Group, Gojek and UOB.

Ningbo Water Meter has contributed to a $77.6m round for the IoT chip manufacturer, which also counts Septwolves as an existing investor.

The stem cell therapy developer, exploiting research from Digital Photonics and Nanoscience Laboratory, has set up a US subsidiary.

Main Sequence Ventures has returned for Prospection’s series B round, having already participated in the company’s $6.7m series A last year.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Cornell spinout Lexeo Therapeutics has added $100m to its coffers thanks to a series B round co-led by D1 Capital Partners and Eventide Asset Management.

Amgen, Bristol Myers Briggs and Vertex Pharmaceuticals were among the investors that brought the gene therapy developer’s overall funding to over $164m.

The gene therapy developer secured backing from Lundbeck and Alexandria Real Estate Equities in a series B round that will support the advancement of its clinical pipeline.